Cookson Peirce & Co’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$263K Buy
+915
New +$263K 0.01% 251
2023
Q1
Sell
-4,836
Closed -$1.35M 260
2022
Q4
$1.35M Sell
4,836
-360
-7% -$100K 0.09% 88
2022
Q3
$1.09M Buy
5,196
+43
+0.8% +$9K 0.08% 98
2022
Q2
$1.21M Buy
+5,153
New +$1.21M 0.08% 95
2022
Q1
Sell
-3,680
Closed -$795K 249
2021
Q4
$795K Buy
3,680
+258
+8% +$55.7K 0.04% 125
2021
Q3
$632K Buy
3,422
+277
+9% +$51.2K 0.04% 137
2021
Q2
$564K Buy
3,145
+202
+7% +$36.2K 0.04% 146
2021
Q1
$492K Buy
+2,943
New +$492K 0.03% 126
2015
Q4
Sell
-2,925
Closed -$384K 160
2015
Q3
$384K Sell
2,925
-1,321
-31% -$173K 0.06% 112
2015
Q2
$739K Buy
4,246
+40
+1% +$6.96K 0.12% 90
2015
Q1
$725K Buy
4,206
+530
+14% +$91.4K 0.13% 90
2014
Q4
$476K Buy
+3,676
New +$476K 0.1% 97
2014
Q2
Sell
-37,300
Closed -$3.51M 164
2014
Q1
$3.51M Sell
37,300
-1,555
-4% -$146K 0.88% 40
2013
Q4
$4.39M Buy
+38,855
New +$4.39M 1.16% 29